Key Financial Data Of Group

Fuji Pharma Co.,Ltd. - Filing #7290798

Concept As at
2024-09-30
2023-10-01 to
2024-09-30
As at
2024-09-30
2023-10-01 to
2024-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
As at
2023-09-30
2022-10-01 to
2023-09-30
2021-10-01 to
2022-09-30
As at
2022-09-30
As at
2022-09-30
2021-10-01 to
2022-09-30
As at
2021-09-30
2020-10-01 to
2021-09-30
As at
2021-09-30
2020-10-01 to
2021-09-30
2019-10-01 to
2020-09-30
As at
2020-09-30
As at
2020-09-30
2019-10-01 to
2020-09-30
Key financial data of group
Business results of group
Net sales
41,925,000,000 JPY
46,138,000,000 JPY
37,421,000,000 JPY
40,889,000,000 JPY
32,554,000,000 JPY
35,426,000,000 JPY
31,859,000,000 JPY
33,990,000,000 JPY
31,260,000,000 JPY
33,793,000,000 JPY
Ordinary profit (loss)
3,953,000,000 JPY
4,445,000,000 JPY
4,071,000,000 JPY
4,519,000,000 JPY
3,395,000,000 JPY
3,725,000,000 JPY
3,319,000,000 JPY
3,250,000,000 JPY
2,807,000,000 JPY
2,983,000,000 JPY
Profit (loss) attributable to owners of parent
6,146,000,000 JPY
3,435,000,000 JPY
2,696,000,000 JPY
2,432,000,000 JPY
2,085,000,000 JPY
Comprehensive income
5,288,000,000 JPY
6,259,000,000 JPY
3,892,000,000 JPY
2,902,000,000 JPY
1,492,000,000 JPY
Net assets
45,563,000,000 JPY
42,361,000,000 JPY
38,977,000,000 JPY
41,177,000,000 JPY
34,508,000,000 JPY
35,806,000,000 JPY
32,595,000,000 JPY
32,681,000,000 JPY
39,596,000,000 JPY
39,961,000,000 JPY
Total assets
90,000,000,000 JPY
83,659,000,000 JPY
79,995,000,000 JPY
85,332,000,000 JPY
71,263,000,000 JPY
75,538,000,000 JPY
62,085,000,000 JPY
64,239,000,000 JPY
59,288,000,000 JPY
61,962,000,000 JPY
Net assets per share
1,873.52
1,741.96
1,603.83
1,694.23
1,420.42
1,473.73
1,342.10
1,345.56
1,270.79
1,282.43
Basic earnings (loss) per share
238.94
252.85
128.27
141.37
102.10
111.01
95.10
90.54
64.70
66.94
Diluted earnings per share
Equity-to-asset ratio
0.506 xbrli:pure
0.506 xbrli:pure
0.487 xbrli:pure
0.483 xbrli:pure
0.484 xbrli:pure
0.474 xbrli:pure
0.525 xbrli:pure
0.509 xbrli:pure
0.668 xbrli:pure
0.645 xbrli:pure
Rate of return on equity
0.143 xbrli:pure
0.142 xbrli:pure
0.085 xbrli:pure
0.089 xbrli:pure
0.074 xbrli:pure
0.079 xbrli:pure
0.071 xbrli:pure
0.067 xbrli:pure
0.051 xbrli:pure
0.053 xbrli:pure
Price-earnings ratio
5.33 xbrli:pure
5.03 xbrli:pure
9.09 xbrli:pure
8.25 xbrli:pure
10.13 xbrli:pure
9.31 xbrli:pure
12.30 xbrli:pure
12.92 xbrli:pure
19.31 xbrli:pure
18.66 xbrli:pure
Net cash provided by (used in) operating activities
4,151,000,000 JPY
1,917,000,000 JPY
-658,000,000 JPY
5,993,000,000 JPY
5,770,000,000 JPY
Net cash provided by (used in) investing activities
-1,658,000,000 JPY
-5,240,000,000 JPY
-11,271,000,000 JPY
-2,345,000,000 JPY
-2,616,000,000 JPY
Net cash provided by (used in) financing activities
-435,000,000 JPY
1,915,000,000 JPY
5,094,000,000 JPY
-5,435,000,000 JPY
450,000,000 JPY
Cash and cash equivalents
4,585,000,000 JPY
2,324,000,000 JPY
3,546,000,000 JPY
10,199,000,000 JPY
12,041,000,000 JPY
Number of employees
1,658 xbrli:pure
902 xbrli:pure
866 xbrli:pure
1,621 xbrli:pure
817 xbrli:pure
1,560 xbrli:pure
791 xbrli:pure
1,532 xbrli:pure
779 xbrli:pure
1,550 xbrli:pure
Average number of temporary employees
87 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.